U.S. RESEARCH ROUNDUP-Nvidia, Albemarle, Dropbox
U.S. RESEARCH ROUNDUP-Albemarle, Dropbox, Tyler Technologies
Brief: Calcimedica Announces FDA Clearance Of Ind Application For Phase 2 Trial Of Auxora™
Brief: Calcimedica Files For Resale Of Up To 10.7 Mln Shares By Selling Stockholders - SEC Filing
Brief: Calcimedica Announces Private Placement Of Up To Approximately $55 Million
Brief: Calcimedica Reports Third Quarter 2023 Financial Results And Provides Clinical & Corporate Updates
Brief: Calcimedica Files For Mixed Shelf Of Up To $100 Million - SEC Filing
CalciMedica Inc reports results for the quarter ended in June - Earnings Summary
Brief: Calcimedica Announces First Patient Enrolled In International Expansion Of Carpo Trial Of Auxora In Acute Pancreatitis
CalciMedica Inc expected to post a loss of $1.04 a share - Earnings Preview
Brief: CalciMedica - Common Stock To Commence Trading On Nasdaq on June 14
U.S. STOCKS ON THE MOVE-CalciMedica, Natgas firms,
CalciMedica rises as Oppenheimer initiates 'outperform' rating on drug sales potential
Brief: Calcimedica Reports Cash And Cash Equivalents Of About $34 Million As Graybug Vision Merger Close Expected To Support Operations Into H2 Of 2024
Brief: Graybug Vision Receives Notice Of Delisting From Nasdaq
Brief: Graybug And Calcimedica Enter Into Definitive Merger Agreement
Graybug Vision Inc reports results for the quarter ended in September - Earnings Summary
Brief: Graybug Vision Inc Reports Quarterly Loss Per Share Of $0.46
Graybug Vision Inc expected to post a loss of 44 cents a share - Earnings Preview